Additional Flu Vaccine Supply: FluMist® Quadrivalent Intra-nasal

Advisory Alert

December 4, 2020

*Cette information est seulement disponible en anglais.

To: Local Health System Partners


Ontario acquires 200 000 doses of FluMist® Quadrivalent Vaccine to address increased demand for flu vaccine

Due to concerns related to the simultaneous circulation of influenza and COVID-19, there has been greater uptake of the flu vaccine this year. To meet the needs of the population, the province has been investigating means to procure additional doses of the vaccine. This advisory alert announces the purchase of 200 000 doses of FluMist® from AstraZeneca by the province and provides key information about the vaccine.

FluMist® Key Information


Original Signed By

Dr. Penny Sutcliffe
Medical Officer of Health and Chief Executive Officer

NOTE: All Advisory Alerts are found on our website.

This item was last modified on December 4, 2020